Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

385.75INR
3:57pm IST
Change (% chg)

Rs2.30 (+0.60%)
Prev Close
Rs383.45
Open
Rs382.50
Day's High
Rs387.50
Day's Low
Rs377.55
Volume
4,480,306
Avg. Vol
6,456,270
52-wk High
Rs679.30
52-wk Low
Rs344.55

Select another date:

Tue, Jun 11 2019

BUZZ-India's Sun Pharma at near 4-week low; chart points to more downside

** Shares of Sun Pharmaceutical Industries Ltd fall about 4% to 386 rupees, their lowest since May 16

MEDIA- Sun Pharmaceutical plans to start developing its own medicines - Bloomberg

-- Note: Reuters has not verified this story and does not vouch for its accuracy

BUZZ-India's Sun Pharma may test a support at 367 rupees - Technicals

** Shares of Sun Pharmaceutical Industries Ltd, down as much as 7.2%, may test a support at 366.88 rupees

Indian shares snap losing spree, inflation data lifts sentiment

May 14 Indian shares snapped a nine-session losing spree to end higher on Tuesday, with pharmaceutical stocks among the top boost, a day after the country's retail inflation data brought hopes of a key interest rate cut in June.

BUZZ-India's Sun Pharma falls after U.S. FDA observations on co's Dadra plant

** U.S. FDA on Friday issued Form 483 with 11 observations after inspection of co's Dadra facility during March 22-29

MEDIA-SEBI asks India's Sun Pharma to explain alleged fund diversion of 420 bln rupees - Business Standard

- Note: Reuters has not verified this story and does not vouch for its accuracy

Sun Pharma third-quarter profit jumps four-fold on strong U.S. show

India's largest drugmaker by market value Sun Pharmaceutical Industries Ltd posted a nearly four-fold jump in quarterly profit on Tuesday, breezing past estimates on strong sales in the U.S. market.

UPDATE 1-India's Sun Pharma Q3 profit jumps four-fold on strong U.S. show

Feb 12 India's largest drugmaker by market value Sun Pharmaceutical Industries Ltd posted a nearly four-fold jump in quarterly profit on Tuesday, breezing past estimates on strong sales in the U.S. market.

India's Sun Pharma Q3 profit rises nearly four-fold, beats estimate

Feb 12 Sun Pharmaceutical Industries Ltd , India's largest drugmaker by market value, posted a nearly four-fold jump in quarterly profit on Tuesday, beating estimates.

Select another date: